Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling.
about
Stress-Related Immune Markers in Depression: Implications for TreatmentReview article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel diseaseGammadelta T cells are reduced and rendered unresponsive by hyperglycemia and chronic TNFalpha in mouse models of obesity and metabolic diseaseImmunomodulatory activity of interferon-betaNeuroimmune mechanisms in Krabbe's diseaseCalcineurin and vacuolar-type H+-ATPase modulate macrophage effector functionsOpinion: Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetesDepression and immunity: a role for T cells?Modulation of allergic inflammation in mice deficient in TNF receptors.Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungsOn the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.Left-sided cardiac valvulitis in tristetraprolin-deficient mice: the role of tumor necrosis factor alpha.Tumor necrosis factor-alpha and the progression of diabetes in non-obese diabetic mice.The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.Tumour necrosis factor and other cytokines in murine lupus.Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis.Detection of Mycobacterium tuberculosis group organisms in human and mouse joint tissue by reverse transcriptase PCR: prevalence in diseased synovial tissue suggests lack of specific association with rheumatoid arthritisMannan-binding lectin enhances susceptibility to visceral leishmaniasis.Adenoviral transgene delivery provides an approach to identifying important molecular processes in inflammation: evidence for heterogenecity in the requirement for NFkappaB in tumour necrosis factor production.Sjögren's syndrome: current therapies remain inadequate for a common disease.The role of TNF-alpha in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: analysis of dendritic cell maturationTumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice.Attenuated EAN in TNF-α deficient mice is associated with an altered balance of M1/M2 macrophages.Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?Glial expression of tumor necrosis factor in transgenic animals: how do these models reflect the "normal situation"?Multiple roles for tumor necrosis factor-alpha and lymphotoxin alpha/beta in immunity and autoimmunity.Studies of T-cell activation in chronic inflammation.Immune system to brain signaling: neuropsychopharmacological implications.Induction of immune tolerance by dendritic cells: implications for preventative and therapeutic immunotherapy of autoimmune disease.Impaired antibody response to influenza vaccine in HIV-infected and uninfected aging women is associated with immune activation and inflammation.Tumour necrosis factor alpha in systemic lupus erythematosus and anti-DNA autoantibody production.Immunopathology and the gene therapy of lupus.Cytokines and immunopathogenesis of intraocular posterior segment inflammation.Control of myeloid activity during retinal inflammation.Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity.Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis.Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors.No signs of immunoactivation in the cerebrospinal fluid during treatment with infliximab.Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factorOligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy.
P2860
Q26771607-F2A22683-3B48-4F4D-9AB0-EE5713005C95Q26822029-522BF630-C9C7-4C0E-AE6C-AAF1BF6D9BFAQ27324312-07BA61B8-ACA7-42B3-84F9-4B4278963154Q27686768-16C287FB-47A9-4C81-A1BA-6B85A6358891Q28079115-536E6BAA-3597-4A30-B3BD-D4680094F7CAQ28343342-92B8EF54-96D7-464D-8D48-99431A4E4565Q29393228-A61C2C24-7041-43EF-B6C9-795E4AB6491EQ30477752-94BBD46E-01C0-4DDF-BEAC-4EC627406C58Q33181448-F4B7C530-910A-4BDD-B1BA-153FFB5A1BDEQ33315753-7F67EDA4-70CE-4528-B9AC-AC08BAE45070Q33333935-29023F94-91FC-4A0E-9887-E77F1F11ADB4Q33703816-1A854AB2-1AD7-478A-815B-310F157C3C20Q33713257-E52E8738-3EE0-47C0-8E81-6DC66F2FA81BQ33782327-304CA21E-CE9E-4971-AF6C-7B6FCC773DA6Q33782338-F3932C4E-D088-4E85-B0DB-FC087C7B3506Q33864445-EB02B067-1BCD-4739-9479-74CB3C3609C2Q34006506-909D8207-686B-4EC8-B372-759E00C0F9C2Q34008749-82EB8E63-B2BE-48AE-AF31-62E6A888706BQ34071292-446A93ED-7071-4460-A143-35B825587C22Q34075047-CAAB317D-0193-4C04-9175-6DF4B13ADC8DQ34116134-D8B70F14-7805-43C4-BEC2-64564CA16270Q34155881-EC35AAD5-8E37-458B-A74A-1EAD0BEDC3CDQ34292861-8DBD2767-7D4D-4A1F-B40D-404B7D5FC8EDQ34395739-10050FAE-74E0-4F86-AAA1-DEC1092C94F3Q34398665-F21E3EB2-7298-464F-8F55-BCFC8E123D5CQ34731168-865025BD-D973-49B9-8188-E576DEFEAD9AQ34731209-2FB308B3-48E5-4215-9251-38702920C9D5Q34769827-8089EEFD-2D97-4198-8604-D323B84D9251Q34983446-73202405-2A66-427A-A7F0-107664710448Q35043898-35731BC8-4A5D-44B2-AB56-4DCCAA8E3785Q35045910-7752F2CA-71EB-4E25-A9E9-9CD7A8D4B929Q35122166-314F4E7E-C6AA-4188-AD9D-322E48E3E255Q35174889-6433062D-7810-48A4-B0CE-639B2F829368Q35186801-EFCA4FC8-50C0-4759-994C-2A64A9F4E9B7Q35190025-7254F42B-9D98-4252-8229-13BA222401ECQ35364243-BA7A7788-3B86-4BDC-BD80-0CA7CD34F151Q35550051-D66D1373-0943-4AAB-90A9-98FB6FEB6EE1Q35637868-9AB686F6-A6DF-4454-BBC2-2CCDCF542150Q35753319-A9D7869C-1951-483E-BDCF-31FD0D118B27Q35753349-CF2E0EBF-7C83-4E66-A7C1-B8CD9454DFCB
P2860
Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Chronic tumor necrosis factor ...... ing T cell receptor signaling.
@ast
Chronic tumor necrosis factor ...... ing T cell receptor signaling.
@en
type
label
Chronic tumor necrosis factor ...... ing T cell receptor signaling.
@ast
Chronic tumor necrosis factor ...... ing T cell receptor signaling.
@en
prefLabel
Chronic tumor necrosis factor ...... ing T cell receptor signaling.
@ast
Chronic tumor necrosis factor ...... ing T cell receptor signaling.
@en
P2093
P2860
P356
P1476
Chronic tumor necrosis factor ...... ing T cell receptor signaling.
@en
P2093
Laudanna C
McDevitt HO
Schreiber RD
P2860
P304
P356
10.1084/JEM.185.9.1573
P407
P577
1997-05-01T00:00:00Z